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Background: Exposure to ozone activates innate immune function and causes neutrophilic (PMN) airway
inflammation that in some individuals is robustly elevated. The interplay between immuno-inflammatory function
and genomic signaling in those with heightened inflammatory responsiveness to ozone is not well understood.
Objectives: Determine baseline predictors and post exposure discriminators for the immuno-inflammatory
response to ozone in inflammatory responsive adult volunteers.
Methods: Sputum induction was performed on 27 individuals before and after a two hour chamber exposure to
0.4 ppm ozone. Subjects were classified as inflammatory responders or non-responders to ozone based on their
PMN response. Innate immune function, inflammatory cell and cytokine modulation and transcriptional signaling
pathways were measured in sputum.
Results: Post exposure, responders showed activated innate immune function (CD16: 31,004 MFI vs 8988 MFI;
CD11b: 44,986 MFI vs 24,770 MFI; CD80: 2236 MFI vs 1506 MFI; IL-8: 37,603 pg/ml vs 2828 pg/ml; and IL-1β:
1380 pg/ml vs 318 pg/ml) with muted signaling of immune cell trafficking pathways. In contrast, non-responders
displayed decreased innate immune activity (CD16, CD80; phagocytosis: 2 particles/PMN vs 4 particles/PMN) post
exposure that was accompanied by a heightened signaling of immune cell trafficking pathways.
Conclusions: Inflammatory responsive and non responsive individuals to ozone show an inverse relationship
between immune cell trafficking and immuno-inflammatory functional responses to ozone. These distinct genomic
signatures may further our understanding about ozone-induced morbidity in individuals with different levels of
inflammatory responsiveness.
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Ozone (O3) is an important criteria air pollutant known
to induce exacerbation of asthma and other airway dis-
eases [1,2]. Human challenge studies have shown that O3
exposure causes an immediate nociceptive decrease in
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reproduction in any medium, provided the or[3] and enhanced response to allergens in allergic volun-
teers [4,5]. O3 also induces airway inflammation in healthy
and asthmatic volunteers that is marked by inflammatory
cell (i.e. neutrophil (PMN)) influx to the airways [6,7]. In
healthy volunteers, the inflammatory response in the air-
ways can occur at O3 levels near (0.08 ppm) or below
(0.06 ppm) the National Ambient Air Quality Standard
(NAAQS) for ambient O3 with noted variability across
individuals, such that some are very responsive while
others have a very weak inflammatory response, suggest-
ing the presence of a inflammatory response phenotype in
humans [8,9]. Previous studies in healthy adults [10] as. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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such as the GSTM1null genotype, can act as genetic
modifiers of the inflammatory response to O3 and may
explain some of the individual variation often observed.
At present, the role inflammatory responsiveness plays in
O3 susceptibility is unclear, and its association with
ozone-induced changes in innate immune function and
host defense genomic signatures remain largely unknown.
In this study, our goal was to characterize factors in
the airways that may contribute to the differential re-
sponse of adult volunteers to ozone. Various cellular fea-
tures associated with ozone responsiveness in the
airways were assessed including the inflammatory re-
sponse, innate immune function and transcriptional sig-
naling both before and after ozone exposure. We
stratified a cohort of 13 healthy, 4 atopic and 10 allergic
asthmatic subjects on the basis of their PMN response
to O3 into a responder and non-responder group. The
inflammatory response was defined as the difference in
% PMNs pre versus post exposure, and a PMN response
of >10% successfully distinguished responders from non-
responders as previously reported [12-14]. Our analysis
focused on establishing cell-associated differences in
sputum at baseline and post exposure in inflammatory
responders and non-responders. Cells recovered from
sputum derive from the lumen of the large central air-
ways and thus reflect pathophysiologic cellular events
in the large airways [15]. Specifically, we analyzed (1)
genomic signatures, (2) biological indicators of innate
immune function and (3) cellular and fluid phase mar-
kers of inflammation in order to determine whether
these indicators were constitutively predictive at base-
line and/or discriminatory post exposure of the inflam-
matory responder phenotype in adult volunteers.
Furthermore, as it is unclear whether asthma or atopy
status is associated with the inflammatory response
phenotype, we examined the relationship of asthma and
atopy status in our cohort of responders and non-
responders.
We demonstrate that ozone responders and non-
responders can be differentiated both at baseline and
post exposure using various cellular indicators. Most
strikingly, we find that ozone-induced activation of in-
nate immune function and inflammation is negatively
associated with genomic signaling of immune cell traf-
ficking networks. Specifically, responders and non
responders have opposite genomic responses in terms of
activation of immune cell trafficking. In addition, we
show that responders compared to non responders have
elevated expression of pro-inflammatory cytokines IL-8
and Il-1b at baseline, suggesting a primed inflammatory
state, but simultaneously possess muted innate immune
function. Asthma or atopy status per se does not influ-
ence the inflammatory response phenotype.Methods
Subjects
Twenty seven adult subjects (13 healthy, 4 allergic non
asthmatics, 10 allergic asthmatics), aged 21 – 35 years,
with no history of smoking in the past 10 years, com-
pleted the study (Table 1). All subjects underwent a
physical examination, a routine blood panel with
complete blood cell count, and differential and allergy
skin testing for common allergens (cat, cockroach, dust,
grass, mite, shellfish, tree, weeds). Healthy subjects were
required to have a negative methacholine challenge test
result, and asthma status was confirmed by clinical his-
tory and positive (≥8 mg/ml) methacholine challenge
test. No asthmatics were receiving oral or inhaled cor-
ticosteroid therapy but all used albuterol on an as
needed basis. Female subjects were required to have a
negative urine pregnancy test result before challenge,
and all volunteers were required to be free of chronic
cardiovascular or respiratory illness (excluding asth-
matics) and be free of acute respiratory illness (for asth-
matics, no exacerbations requiring oral or inhaled
corticosteroids) within 4 weeks of O3 challenge. All sub-
jects had FEV1 and forced vital capacity (FVC) values of
80% or greater of predicted value and FEV1/FVC ratios
of 75% or greater of predicted normal value for height
and age. All subjects were screened for their ability to
provide an adequate induced sputum sample during
their training sessions 48 hours prior to exposure and
this sample acted as their pre-exposure baseline. Pre and
post sputum samples were separated by a minimum of
48 hours. The study protocol was approved by the
Institutional Review Board at the University of North
Carolina Medical School in Chapel Hill and the US
Environmental Protection Agency (EPA), and informed
consent was obtained from all subjects before their par-
ticipation in the study.
Ozone (O3) exposure and testing protocol
The O3 exposures were conducted in an exposure
chamber at the EPA Human Studies Facility on the
campus of the University of North Carolina (Chapel Hill,
NC). Each subject was exposed to 0.4 ppm O3 for two
hours while performing four 15-minute sessions of inter-
mittent moderate exercise (expiratory minute ventila-
tion, 30–40 L/min) on a treadmill, separated by
15 minutes of seated rest. Lung function, breath sounds,
and vital signs were assessed immediately before and
after exposure.
Sputum collection and analysis
Sputum was obtained 5 hours after exposure and pro-
cessed as previously described [10]. Sputum samples
were used as O3 preferentially absorbs in the large cen-
tral airways during exercise [16], the same region from
Table 1 Subject demographic data
Responders Height (cm) Weight (kg) Age (yr) Gender Race Smoker Diagnosis Minute ventilation (Vmin)
01 157 61.2 21 Female Caucasion no healthy 36.8
02 195 81.8 20 Male Caucasion no healthy 29.5
03 171 53.8 30 Male Caucasion no healthy 28.3
04 180 83 31 Male Asian no healthy 27.3
05 182 78.6 23 Male Caucasion no healthy 37.3
06 170 58.5 28 Female Caucasion no healthy 35.5
07 153 48.7 22 Female Caucasion no healthy 30
08 159 75.4 22 Female Caucasion no healthy 32
09 186 66.6 23 Male Caucasion no atopic + ve skin test 32.8
10 167 77.4 35 Male African American no atopic + ve skin test 34
11 173.5 82.5 22 Male Caucasion no atopic + ve skin test 31.3
12 168 92.3 39 Female Caucasion no atopic asthmatic 34.3
13 181 75.1 20 Male allergic asthmatic no atopic asthmatic 33.3
14 168 97.3 20 Female allergic asthmatic no atopic asthmatic 30.4
15 178 74.2 31 Female Caucasion no atopic asthmatic 35
16 167 69.3 27 Female Caucasion no atopic asthmatic 32.5
17 170 52 22 Female Caucasion no atopic asthmatic 30.8
18 165 73.4 25 Female Caucasion no atopic asthmatic 31.5
Mean (+/− SEM) 172 (3) 72 (3) 26 (1) 33 (1)
Non-Responders
01 193 94.8 26 Male Caucasion no healthy 32.1
02 156 56.3 27 Female Caucasion no healthy 30.8
03 162 59.1 25 Female Caucasion no healthy 34.8
04 172.25 70.9 24 Female Caucasion no healthy 33.8
05 157 77.9 26 Female Caucasion no healthy 28.3
06 158 68.4 20 Male Caucasion no atopic + ve skin test 32.3
07 155 60.6 25 Female Caucasion no atopic asthmatic 33
08 173 64.8 27 Male Causasion no atopic asthmatic 31.8
09 178 64 20 Male Caucasion no atopic asthmatic 33.5
Mean (+/− SEM) 167 (4) 69 (4) 24 (1) 32 (1)
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7-minute inhalation periods of nebulized hypertonic sa-
line (3%, 4%, and 5%; UltraNeb 99 ultrasonic nebulizer;
DeVilbiss, Jackson, TN) were followed by expectoration
of sputum into a sterile specimen cup. Cell-rich “plug”
material was selected from the raw sample and treated
with a dilute (0.1%) solution of dithiothreitol (Sputolysin;
Calbiochem, San Diego, CA) in Dulbecco PBS. Aliquots
of sputum supernatant were collected and immediately
frozen and stored at −80°C for future cytokine measure-
ment, and the cell pellet was analyzed for cell viability
(trypan blue exclusion), total cell count and differential
leukocyte counts (Hema-Stain-3; Fisher Scientific,
Hampton, NH). A portion of the remaining cells were
also used for cell surface immunophenotyping (CD11b,mCD14, HLA-DR, CD16, CD80, CD86) as assessed by
flow cytometry as previously described [10]. Acquired
sputum samples considered acceptable for processing
had a minimum of 75 mg of selected plug material, cell
viability greater than 50%, and squamous epithelial cells
less than 40%. All sample processing, including flow
cytometric assays and slide preparations, were per-
formed on the same day of collection. Flow analysis was
performed on fixed samples (0.5% paraformaldehyde)
within 24 hours of acquisition on a BD LSR-II flow cyt-
ometer (BD Immunocytometry Systems, San Jose, CA).
Cytokines were measured using multi-plex technology
(Meso ScaleDiscovery/MSD, Gaitherburg, MD). Each
sample was analyzed with the Human MIP-1 alpha Ultra
Sensitive Kit (lot no. K0031370) and the Human TH1/
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supernatant samples were diluted 1:4 and had a final
dithiothreitol (DTT) concentration of less than 1 mmol/L
where no deleterious effects from the DTT have been
observed with the MSD platform.
Functional assays for oxidative burst activity and
phagocytosis of opsonized zymosan were also assessed
on sputum inflammatory cells by means of flow cytome-
try as previously described [10]. Several phagocytosis
parameters were assessed including the percentage of
internalized (vs externally adhered) zymosan particles
using Trypan Blue stain as the quenching reagent.
Classification of the ozone induced inflammatory
response
Subjects demonstrated a range of responsiveness with
respect to airway neutrophil proportion (%) following
ozone exposure (Figure 1A). Inflammatory responsive-
ness was defined as the % PMN post -% PMN pre O3
exposure. In general, individuals could be grouped as
those with a minimal inflammatory response or “non-
responders” (N = 9) and those with a robust inflamma-
tory response or “responders” (N = 18). An inflammatory
response (% PMN post -% PMN pre O3) ≥ 12 was used
to distinguish inflammatory responders and non-
responders and is a similar criteria as used previously by
our group and others [12-14]. The mean ozone “re-
sponse” for all endpoints is defined as the mean of the
sum of the individual subject differences between post
and pre exposure.
FEV1 response
Spirometry was performed on a 10.2-L dry seal digital
spirometer interfaced to a computer (SensorMedics
Model 1022; SensorMedics; Palm Springs, CA). At least
three sets of qualified data were obtained and the largest
value selected for FEV1 and FVC as per American Thor-
acic Society guidelines [17]. Pulmonary function on all
subjects was measured using one dedicated spirometer
and by one certified pulmonary function technician toA B
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Figure 1 Ozone response for neutrophils differs between responders
responders are distinguished on the basis of their PMN response (% PMN p
than 12 for non-responders and greater than 12 for responders. (B) The pre
responders with ozone exposure, as well as the responders versus non-respminimize variability. Measurements were performed be-
fore and immediately after exposure for use in endpoint
analysis.RNA Labeling
Total sputum RNA was prepared with Trizol (Invitrogen,
Carlsbad, CA) homogenization and QiagenRNeasy
column purification (Valencia, CA) according to manu-
facturer’s protocols. RNA integrity was assessed by com-
paring 18S and 28S rRNA species using a Bioanalyzer
(Agilent Technologies, Inc., Santa Clara, CA). RNAs
from each group were labeled by amino-allyl nucleotide
incorporation and reverse transcription with SuperScrip-
tIII (Invitrogen) according to manufacturer’s protocol
(Epicentre Biotechnologies, Madison, WI). Probes were
then coupled to fluorescent-labeled cy dyes (GE Health-
care, Piscataway, NJ), such that the experimental sam-
ples were Cy5 (red) labeled while the human
universal reference RNA (Stratagene/Agilent) sample
was Cy3 (green) labeled.Microarray analysis
Each Cy5 sample aRNA probe was paired with Cy3
reference aRNA probe and hybridized to microarrays in
formamide-containing buffer overnight at 42°C using a
Maui Hybridization System (BioMicro Systems Inc., Salt
Lake City, UT). The custom-designed microarray con-
sisted of 70-mer oligonucleotides representing more
than 2000 immune response gene targets. Commercially
available and custom-designed oligos were purchased
from Operon Biotechnologies, Inc. (Huntsville, AL) and
printed onto glass slides by the Duke Microarray Facility
(Duke University, Durham, NC). Each microarray con-
tained targets replicate-spotted four times. The gene tar-
get pool also included housekeeping genes (i.e. ACTB,
GAPD, TUBA, ribosomal proteins RPL13A, RPS9) used
as internal references, negative background controls and
known “spiked-in” RNA oligos (Applied Biosystems,
Austin, TX). Technical replicate assays were performed.Pre Ozone
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Fry et al. Respiratory Research 2012, 13:89 Page 5 of 11
http://respiratory-research.com/content/13/1/89Microarray data analysis
The hybridized spot intensities were acquired using a
GenePix 4000B scanner (Molecular Devices Corp,
Sunnyvale, CA) and assessed using GenePix Pro 6.0 soft-
ware. Median pixel intensities (with background sub-
tracted) were uploaded in GeneSpring 10 (Agilent
Technologies, Inc., Santa Clara, CA), normalized by glo-
bal LOWESS fit [18], log base 2 transformed, filtered
so as to exceed the background and spot quality criteria
(i.e.“Absent” probes were not included) and merged into
datasets. Gene lists and hierarchical clusters of differen-
tially expressed genes were generated. The use of R soft-
ware through Bioconductor was examined to analyze
hybridization signal intensities [19,20]. To control for
multiple comparison, we used false discovery rate (FDR),
estimated by 5000 permutations for each gene.
Network analysis and enriched canonical pathways
Molecular network and enriched canonical pathway
analysis was performed using the Ingenuity database
(Ingenuity Systems, www.ingenuity.com, Redwood City,
CA). The Ingenuity database provides a collection of
gene to phenotype associations, molecular interactions,
regulatory events, and chemical knowledge accumulated
to develop a global molecular network. The lists of dif-
ferentially expressed mRNAs were overlaid onto this glo-
bal molecular network, where protein networks strongly
associated with the targets were algorithmically con-
structed based on connectivity. Statistical significance of
each network was calculated using a Fisher’s exact test.
This test generated a p value representing the intercon-
nectivity between genes, indicating the likelihood of the
gene products interacting by chance alone. Enriched ca-
nonical pathways within these networks were also identi-
fied, where a Fischer’s exact test was used to identify
significantly associated canonical pathways. Canonical
pathways with p < 0.01 were assessed.
Statistical methods
Baseline responses and O3 responses for all phenotype
endpoints were compared using a Student’s T-test (using
Prism version 5.01). In cases where data were not nor-
mally distributed, non-parametric tests (Mann Whitney)
were used. The relationship between O3-induced inflam-
matory response and asthma status was analyzed using
an exact chi-square test and the Mantel-Haenszel chi-
square using S.A.S. (S.A.S, version 9.2). A p value of
<0.05 was considered statistically significant.
Results
Inflammatory (PMN) response phenotype: ozone (O3)
responders and non-responders
Sputum samples were collected from 27 volunteers
exposed to 0.4 ppm O3 for two hours. Differential cellcount analysis showed non-responders (N = 9) to have a
minimal PMN response of 0.6% (±3%), while responders
(N= 18) had a significant (p = 0.0001) PMN response of
35% (±3%) (Figure 1A). Post exposure, PMN levels were
significantly (p = 0.03) higher in responders compared to
non-responders as expected, while baseline % PMN
levels did not differ between inflammatory responders
and non-responders (Figure 1B). We note, of the 27 total
subjects, 10 were asthmatic and 4 were atopic without
asthma. The inflammatory response however was not
associated with either atopy or asthma as measured by
chi square analysis (p = 0.69). This was further confirmed
when the subjects’ neutrophil response to ozone were
stratified by disease group and showed no difference
when analyzed by ANOVA (p = 0.9).
FEV1 response in inflammatory responders
and non-responders
Percent predicted FEV1 (%) and the “% predicted FEV1
response” were measured to determine whether lung
function was different at baseline and post ozone expos-
ure in inflammatory responders and non responders.
The mean FEV1 “response” was calculated as the mean
of the sum of the individual subject differences between
post and pre % predicted FEV1. We report that the %
predicted FEV1 was not significantly different between
inflammatory responders and non responders, respect-
ively at pre exposure (106 ± 4% vs 107 ± 4%, p > 0.05) and
post exposure (91 ± 4% vs 93 ± 5%, p > 0.05). The % pre-
dicted FEV1 “response” was also not significantly differ-
ent between responders and non responders (data not
shown).
Specific cytokines increased at baseline and
post exposure
In order to characterize cytokine responses to O3 expos-
ure in inflammatory responders and non-responders,
the levels of eight different cytokines were measured
pre and post exposure (Table 2). At pre exposure, IL-8
was significantly elevated in responders compared to
non-responders. At post exposure, IL-1β and IL-8 were
significantly increased in responders compared to non-
responders. Responders also demonstrated a significantly
greater increase from pre exposure in IL-8 and IL-1β
than non-responders (data not shown). All other cyto-
kines (IL-2, IL-6, TNFα, INFγ, IL-12) remained at rela-
tively stable levels pre or post exposure for both
responders and non-responders.
Modified cell surface phenotype expression in
inflammatory responders and non-responders
Expression, measured as mean fluorescence intensity
(MFI), of cell surface phenotypes on sputum monocytes,
macrophages, neutrophils and dendritic cells was assessed
Table 2 Cytokine levels pre and post ozone exposure
Cytokine (Pg/ml) Responders pre exposure Responders post exposure Non responders pre exposure Non responders post exposure
IL-1β 989 (511) 1380 (672)** 510 (184) 318 (95)
IL-8 20234 (10347)* 37603 (12024)** 3161 (1567) 2828 (1076)
IL-6 104 (38) 304 (89) 343 (152) 348 (138)
IL-10 28 (14) 100 (62) 55 (37) 16 (9)
TNFα 223 (142) 141 (49) 44 (14) 63 (32)
INFγ 204 (56) 272 (74) 105 (37) 138 (51)
IL-12 186 (67) 210 (104) 209 (87) 133 (44)
IL-2 203 (50) 219 (69) 440 (164) 305 (101)
Mean cytokine levels are shown (+/− standard error).
Pg/ml = picograms per mililiter.
* p < 0.05 Responder vs Non Responder pre-exposure; ** p < 0.05 Responder vs Non Responder post-exposure Pre Exposure = 48 hours pre exposure;
Post Exposure = 5 hours post exposure.
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post O3 exposure. The mean O3 “response” for cell sur-
face phenotypes was calculated as the mean of the sum of
the individual subject differences between post and pre ex-
posure MFI values (Table 3). Pre exposure, there were sig-
nificant (p< 0.05) differences in surface marker expression
between responders and non-responders for CD14 and
CD80 on monocytes and CD86 on macrophages. Post ex-
posure, significant differences in expression between
responders and non responders were observed for CD16,
CD80, HLA-DR and CD11b (trend) on macrophages, and
HLA-DR on monocytes. When the mean O3 “response”
was compared between responders and non-responders,
significant (p < 0.05) differences were found for macro-
phage CD11b expression and monocyte CD80 expression.
No other significant differences between responders and
non-responders were found at pre or post exposure or for
the calculated O3 “response” for the other surface pheno-
types measured.
Oxidative burst activity is not changed by ozone
Oxidative burst activity was evaluated pre and post O3
exposure using a functional assay. O3-induced changes
in oxidative burst activity were not significantly different
between inflammatory responders and non-responders
(Table 4). Furthermore, baseline (pre O3) oxidative burst
activity did not significantly differ between responders
and non-responders (Table 4).
Phagocytosis activity varies between inflammatory
responders and non-responders
Phagocytosis, assessed in sputum macrophages and neu-
trophils, was expressed as total phagocytic capacity
(MFI), the percentage of cells undergoing phagocytosis,
the percentage of internalized particles and the internal
to external ratio (I:E ratio) of particle uptake by cells
(Table 5). These indicators were evaluated pre and post
ozone exposure. As shown in Table 5, severalphagocytosis indices were significantly (p < 0.05) different
between inflammatory responders and non-responders
at baseline in both macrophages and neutrophils. Spe-
cifically, responders had a decrease in all phagocytosis
endpoints in macrophages and lower particle internal-
ization in neutrophils compared to non-responders.
Responders did however, show higher total phagocytic
capacity (MFI) in neutrophils suggesting greater particle
adherence to the neutrophil surface but importantly,
a decreased capacity to engulf and internalize the
particle. Post exposure, neutrophil phagocytosis was
significantly increased in responders versus non
responders for total phagocytic capacity and for the
number of particles taken up per neutrophil (Table 5).
The mean O3 “response” (mean of the sum of the
individual subject differences in phagocytosis between
post and pre exposure) by macrophages was not
different between responders and non-responders but
did differsignificantly for neutrophils across several
indices. As shown in Table 5, responders’ neutrophils had
significantly increased internalization capacity following
O3 exposure compared to non-responders who showed
decreased internalization and a decrease in the percentage
of neutrophils undergoing phagocytosis. Altogether,
phagocytosis activity greatly differed between inflamma-
tory responders and non-responders at baseline for both
macrophages and neutrophils, while neutrophils were
specifically affected post O3.Large differences in genomic response between
inflammatory responders and non-responders
A total of 140 genes were identified with significantly
altered expression following O3 (see Additional file 1).
Of these, 120 genes were modulated in the non-
responder group, 13 genes were modulated in the re-
sponder group, and an additional 7 genes were changed
in both groups (Figure 2A). The majority of the altered
Table 3 Cell surface phenotype expression pre and post ozone exposure
Surface
marker
(MFI)
R pre ozone R post
ozone
R ozone
response*
NR pre
ozone
NR post
ozone
NR ozone
response*
Pre
exposure
R vs NR
Post
exposure
R vs NR
Ozone
response
R vs NR
CD11b Mac 23964 (4448) 44986 (9539) 110 (42) 37861 (11770) 24770 (4280) 8 (30) ns P = 0.07 p = 0.05
CD14 Mono 5776 (559) 11800 (1082) 149 (41) 9886 (1016) 19348 (4647) 92 (36) p = 0.004 ns ns
HLA-DR Mono 7399 (849) 10611 (832) 85 (35) 9715 (1412) 15361 (2110) 88 (45) ns P = 0.02 ns
HLA-DR Mac 46144 (3293) 48527 (5232) 9 (13) 60440 (15219) 76424 (9254) 56 (29) ns P = 0.02 ns
CD16 Mac 21259 (6465) 31004 (8624) 100 (38) 8030 (2266) 8988 (2011) 27 (30) ns P = 0.01 ns
CD80 Mono 2956 (603) 2236 (576) 16 (49) 825 (370) 1506 (414) 648 (572) p = 0.01 ns p = 0.01
CD80 Mac 3202 (611) 5178 (1116) 175 (88) 3440 (1642) 2014 (649) 32 (84) ns P = 0.02 ns
CD86 Mac 26012 (2577) 21996 (2422) 172 (193) 42833 (12057) 42135 (9157) 13 (22) p = 0.05 ns ns
CD11b Mono 31267 (4186) 32517 (3789) 34 (25) 27031 (3957) 35935 (6247) 47 (25) ns ns ns
CD11b PMN 48975 (3856) 53935 (6220) 18 (16) 51808 (8185) 59310 (9073) 27 (25) ns ns ns
CD14 Mac 7937 (975) 9516 (973) 66 (50) 18093 (10437) 12001 (2838) 9 (14) ns ns ns
HLA-DR DC 27304 (2787) 27230 (2087) 6 (8) 25986 (3583) 29416 (2101) 28 (25) ns ns ns
CD16 Mono 9422 (1763) 7048 (926) 11 (21) 9511 (4755) 6801 (1847) 15 (27) ns ns ns
CD16 PMN 64160 (10852) 62617 (9331) 23 (25) 65491 (29381) 81816 (26611) 65 (30) ns ns ns
CD86 Mono 6768 (893) 6835 (374) 36 (25) 6973 (895) 10588 (10588) 75 (61) ns ns ns
Mean (+/− standard error) values are shown for each cell surface marker, along with the corresponding cell type.
R=Responders; NR=Non-Responders; MFI =mean fluorescence intensity; Mono =monocyte; Mac =macrophage; PMN=Polymorphonuclear neutrophil;
ns = not significant.
* Ozone Response values were calculated as the mean of the sum of the individual subject differences in expression (MFI) between post and pre exposure.
pre = 48 hours pre exposure; post = 5 hours post exposure.
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(Figure 2B).
To gain further insight into whether the alterations in
gene expression profiles occurred simply as a result of
changes in cell populations, the lists of ozone-modulated
genes in each group were compared to a previously pub-
lished list of 411 genes that have been suggested to be
granulocyte-specific in comparison to other types of leu-
kocytes [21]. Comparing the 13 genes modulated by
ozone in the inflammatory responder group to the
granulocyte-specific genes revealed one gene, neutrophil
cytosolic factor 2 (NCF2), which may have been mea-
sured at increased expression levels resulting from the
increased presence of neutrophils found in the re-
sponder group. However, this gene also showed
increased expression in the non-responder group whichTable 4 Oxidative burst activity pre and post ozone exposure
Oxidative burst
activity (MFI/%)
R pre
ozone
R post
ozone
R ozone
response
NR pre
ozone
Mac 118 (16) 84 (15) −19 (15) 114 (25)
% Mac 55 (8) 36 (7) −20 (20) 52 (12)
PMN 41 (7) 35 (5) 14 (23) 49 (11)
% PMN 73 (8) 58 (7) 35 (58) 65 (11)
Mean (+/− standard error) values are displayed for burst activity (MFI) and % of cell
R=Responders; NR=Non-Responders; MFI =mean fluorescence intensity; Mac
* Ozone Response values were calculated as the mean of the sum of the individual
pre = 48 hours pre exposure; post = 5 hours post exposure.did not show significant changes in neutrophil cell
counts. This comparison gives evidence to suggest that
the changes in genomic signatures induced by ozone do
not reflect changes in neutrophil cell count.
Biological networks potentially affected by O3 expos-
ure were constructed using the genes that showed
altered expression levels in responders and non-respon-
ders. Nine networks were identified using the genes
modified by O3 exposure in non-responders, while only
two networks were identified in the responders (see
Additional files 2 and 3). Figure 3A and 3B show the
biological networks with the highest statistical signifi-
cance for inflammatory non-responders and responders,
respectively. While no genes are shared between the two
most significant networks, both contain the common
transcriptional regulator nuclear factor of kappa lightNR post
ozone
NR ozone
response*
Pre
exposure
R vs NR
Post
exposure
R vs NR
Ozone
response
R vs NR
128 (31) 116 (112) ns ns ns
36 (13) −18 (29) ns ns ns
63 (13) 127 (134) ns ns ns
49 (17) −4 (37) ns ns ns
s undergoing burst response.
=macrophages; PMN=Polymorphonuclear neutrophil; ns = not significant.
subject differences in oxyburst values between post and pre exposure.
Table 5 Phagocytosis activity pre and post ozone exposure
Phagocytosis R pre
ozone
R post
ozone
R ozone
response*
NR pre
ozone
NR post
ozone
NR ozone
response*
Pre
exposure
R vs NR
Post
exposure
R vs NR
Ozone
response
R vs NR
Mac (MFI) 443 (140) 660 (138) 139 (59) 412 (167) 555 (234) 91 (50) ns ns ns
% Mac 34 (4) 35 (4) 17 (15) 51 (6) 44 (8) −14 (13) p = 0.03 ns ns
Particles/Mac 3 (1) 4 (1) 138 (59) 3 (1) 4 (2) 91 (50) ns ns ns
% Internalized Mac 31 (5) 32 (4) 26 (19) 64 (10) 57 (17) −19 (21) p = 0.02 ns ns
Internal:External
Particle Ratio Mac
0.6 (0.2) 0.5 (0.1) 40 (27) 2.1 (0.6) 2.3 (0.9) −7 (42) p = 0.02 ns ns
PMN (MFI) 565 (144) 542 (105) 61 (41) 197 (62) 226 (27) 78 (62) p = 0.03 p = 0.01 ns
% PMN 26 (4) 40 (6) 70 (26) 43 (5) 33 (2) −18 (14) p = 0.01 ns p = 0.01
Particles/PMN 4 (1) 4 (1) 66 (44) 1 (0.3) 2 (0.2) 93 (58) p = 0.03 p = 0.02 ns
% Internalized PMN 29 (4) 46 (5) 95 (37) 72 (15) 65 (14) −5 (13) p = 0.03 ns p = 0.03
Internal: External
Particle Ratio PMN
0.5 (0.1) 1 (0.2) 196 (73) 6 (3) 3 (2) −6 (45) p = 0.03 ns p = 0.04
Mean (+/− standard error) values are displayed for each phagocytic indicator.
R=Responders; NR=Non-Responders; MFI =mean fluorescence intensity; Mac =macrophage; PMN=polymorphonuclear neutrophil; ns = not significant.
* Ozone Response values were calculated as the mean of the sum of the individual subject differences in phagocytosis values between post and pre exposure.
pre = 48 hours pre exposure; post = 5 hours post exposure.
A
NR R
+ FC- FC
Ozone Exposure
NR
120 genes
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Figure 2 Ozone exposure causes a varied genomic response
between inflammatory responders and non-responders. (A)
Human ozone exposure induced significant changes in the
expression of genes, largely within the NR group. (B) A heat map
illustrates the 140 ozone-modulated genes identified as differentially
expressed in at least one subject group exposed to ozone. Blue
indicates negative fold change (FC) in expression (post ozone
challenge / baseline), and red indicates positive FC.
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http://respiratory-research.com/content/13/1/89chain gene enhancer in B cells (NF-κB). An examination
of the functional role of the integrated proteins identifies
a difference in the number of genes that encode immune
cell trafficking-associated proteins. Specifically, the non-
responders showed increased expression levels of
7 immune cell trafficking-associated genes while respon-
ders had a muted response with only 1 immune cell
tracking-associated gene (Figure 3A,B). In particular,
ubiquitin-conjugating enzyme E2N, (UBE2N), v-rel reticu-
loendotheliosis viral oncogene homolog B, (RELB), beta-2-
microglobulin, (B2M), major histocompatibility complex,
class I, C, (HLA-C), leukocyte immunoglobulin-like recep-
tor, subfamily B (with TM and ITIM domains), member 1,
(LILRB1), fragment of IgG, high affinity Ia, receptor
(CD64), (FCGR1AFc), fragment of IgG, low affinity IIIb,
receptor (CD16b), (FCGR3BFc), and cyclin D1, (CCND1)
are genes that encode proteins involved in immune cell
trafficking. It should also be noted that FCGR3B is a gene
that is highly expressed in neutrophils [21]. Taken to-
gether, inflammatory responders displayed activated mar-
kers of inflammation that included IL-8, II-1b and
increased levels of PMN, enhanced immune cell function
and suppressed expression of immune cell trafficking tran-
scripts. In contrast, non-responders demonstrated un-
changed markers of inflammation, activated immune cell
function and up-regulated immune cell trafficking tran-
scripts (Figure 4).
Discussion
We set out to identify whether cellular and biochemical
indicators in sputum collected both at baseline and post
exposure could predict and characterize the inter-
individual differences in adult volunteers who were
phosphatase
direct interaction
indirect interactioncytokine
transmembrane
receptor
enzyme
transcriptional
regulator
transporter
G protein
coupled receptor
growth factor
ion channel
kinasepeptidase
other
-43A -44R  p < 10NR  p < 10 B
*complex
immune cell
trafficking-related
*
*
*
*
****
Figure 3 Differences in genomic signaling networks between inflammatory responders and non-responders. The most significant
networks associated with ozone-induced gene expression changes in (A) inflammatory non-responders and (B) inflammatory responders are
displayed. Networks are shown with symbols representing products of genes that are up-regulated (red symbols) by ozone, down-regulated (blue
symbols) by ozone, or are associated (clear symbols) with the differentially expressed genes. Genes that encode proteins that play a role in
immune cell trafficking are designated with an asterisk (*).
Non-Responders Responders
Ozone Exposure
Activated IL8
Activated IL1B
Increased PMN
Increased innate
immune function
Minimal activation of
immune cell trafficking
pathways
No change in IL8
No change in IL1B
No change in PMN
Decreased innate
immune function
Robust activation of
immune cell trafficking
pathways
Figure 4 Summary of the ozone-induced changes in
non-responders and responders.
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siveness to ozone. Specifically, we examined whether
markers of innate immune function and targeted tran-
scripts for immune cell trafficking were able to predict
and or discriminate between individuals with a robust
(responder) or minimal (non-responder) inflammatoryr-
esponse to inhaled O3.
We report that in a group of 27 adult volunteers, 18
were robust inflammatory responders with a mean O3-
induced increase in % PMNs of 35%, and 9 were non-
responders with a mean O3-induced increase in %
PMNs of 0.6%. Responders also had significantly
elevated levels of pro-inflammatory cytokines IL-8 and
IL-1β. At baseline, neither % PMN levels nor gene expres-
sion profiles differed between inflammatory responders
and non-responders. This was somewhat surprising since
we have shown previously that baseline gene expression
can be used as an indicator of inter-individual responsive-
ness to environmental contaminants [22]. One explanation
could be the limited selection of genes that were analyzed
on the targeted microarray. It is possible that a whole
genome approach would uncover baseline gene predictors
of inflammatory responsiveness to O3.
A select number of biological indicators did however
distinguish the inflammatory phenotypes at baseline. For
the responders, these included significantly decreased
expression of cell surface phenotypes (CD14, CD86)decreased phagocytosis and elevated IL-8 levels, suggest-
ing that at baseline, individuals with the inflammatory
responsive phenotype have muted innate immune func-
tion in concert with a primed potential toward PMN in-
flux due to high pre-existing levels of IL-8.
Post exposure, responders had enhanced inflammation
as demonstrated by increased PMN, IL-8 and IL-1β
levels, and activated immune function in concert with
minimal immune cell trafficking-associated genomic sig-
naling. Interestingly, non responders had the opposite
Fry et al. Respiratory Research 2012, 13:89 Page 10 of 11
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flammation, down-regulated immune function but with
a robust immune cell trafficking genomic response.
These data demonstrate the presence of a negative asso-
ciation between a specific innate immune genomic re-
sponse and immuno-inflammatory functional responses
in the airways. Specifically, up-regulation of genes asso-
ciated with immune cell trafficking appears to be nega-
tively associated with macrophage expression of CD16/
FcRγIII and CD11b/CR3, both of which mediate innate
immune responses, and neutrophil phagocytosis. It is
important to acknowledge that these measurements
were conducted in sputum cells that reflect events in the
large versus distal airways, a compartmentalized re-
sponse to ozone. Inflammatory responses are noted to
be different in large versus distal airways.
Since our cohort of subjects included asthmatics, we
assessed whether disease status conferred an increased
likelihood of being an inflammatory responder or non-
responder. We found that neither asthma nor atopy
(without asthma) significantly predisposed one toward a
particular inflammatory phenotype. This suggests that
although O3 is associated with increased exacerbation
of asthma and can induce greater O3-induced lung
function decline in asthmatics versus non-asthmatics
[23,24], inflammatory responsiveness to O3 may not be
wholly dependent on asthma status or atopy, but when
it occurs in asthmatics, may be a risk factor for asthma
exacerbation.
Following O3 exposure, there were some common
genomic responses between responders and non respon-
ders. These included genes that are associated with in-
flammation, specifically members of the NF-κB pathway.
These data support research that has shown that O3 is
known to cause increases in NF-κB binding activity in
macrophages and type II epithelial cells [25]. Interest-
ingly, while both groups modulated these inflammation-
associated genes, it was the O3 non-responders who
showed an enrichment for genomic signaling related to
immune cell trafficking. Finally, these results identify
through a systems biology approach, novel baseline bio-
logical indicators and post exposure discriminators of in-
flammatory responsiveness to O3. Our data highlight the
complex interplay between innate immune-associated
genomic signaling and immuno-inflammatory functional
responses to ozone, factors that likely influence disease
susceptibility in inflammatory responsive individuals.
It is important to acknowledge that with these intri-
guing data, certain limitations were present in this study.
Most noteworthy, was the mixed sputum cell population
that was used for the gene expression data. Absent a sin-
gle cell population from which to draw conclusions, the
effects of other cell types contributing to the overall gen-
etic signaling cannot be ignored, but in this study forexample, neutrophil levels were not likely responsible for
the observed differences in genomic signatures.
Conclusions
Inflammatory responsive and non responsive individuals
to O3 each demonstrate an inverse relationship between
innate immune genomic signaling and immuno-
inflammatory responses to O3, but do so in opposite
directions. Inflammatory responders have enhanced
immuno-inflammatory function with muted innate im-
mune genomic signaling, while non responders have
decreased immuno-inflammatory function with robust in-
nate immune genomic signaling. These distinctions, par-
ticularly in genomic signaling, may help elucidate the
mechanisms underlying O3-induced morbidity in indivi-
duals with differing levels of inflammatory responsiveness
to O3.
Additional files
Additional file 1: Genes significantly differentially expressed after
ozone challenge.
Additional file 2: Networks constructed using the inflammatory
non-responders’ ozone-associated genes.
Additional file 3: Networks constructed using the inflammatory
responders’ ozone-associated genes.
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